Today: 29 April 2026
Browse Category

NASDAQ:CYPH 12 November 2025 - 10 December 2025

Cypherpunk Technologies (CYPH) Stock: Zcash Treasury Pivot, Winklevoss Backing and 2026 Forecast Explained

Cypherpunk Technologies (CYPH) Stock: Zcash Treasury Pivot, Winklevoss Backing and 2026 Forecast Explained

Cypherpunk Technologies Inc. (NASDAQ: CYPH), formerly Leap Therapeutics, closed at $1.62 on December 9, 2025, up nearly 40% after pivoting from biotech to a Zcash-focused treasury strategy backed by Winklevoss Capital. The stock has seen trading halts, insider sales, and sharp volatility since the rebrand and $58.88 million private placement in October.
10 December 2025
·····
Biggest Stock Gainers Today (December 9, 2025): AFJK, NCPL, XCUR, ALEX and DBI Lead the After‑Bell Rally

Biggest Stock Gainers Today (December 9, 2025): AFJK, NCPL, XCUR, ALEX and DBI Lead the After‑Bell Rally

Aimei Health Technology shares surged 968% to $85.47 Tuesday after the SPAC extended its merger deadline to January 6, 2026, fueling speculation of a pending deal. The S&P 500 closed down 0.02%, while microcap stocks dominated gains, with Oriental Culture Holding up 321% and Netcapital up 122%. Trading in AFJK exceeded 6 million shares, far above its average.
9 December 2025
··········
Cypherpunk Technologies (CYPH) Soars Over 300% on Zcash Pivot – What’s Driving Today’s Volatile Rally? (17 November 2025)

Cypherpunk Technologies (CYPH) Soars Over 300% on Zcash Pivot – What’s Driving Today’s Volatile Rally? (17 November 2025)

Cypherpunk Technologies (NASDAQ: CYPH) shares jumped over 30% in U.S. pre-market trading Monday, reaching about $3.60 and a $155 million market cap. The move follows last week’s rebrand from Leap Therapeutics and a $50 million Zcash purchase backed by Winklevoss Capital. CYPH stock has surged more than 300% since its Nasdaq debut under the new ticker on November 13.
17 November 2025
··
Cypherpunk Technologies (LPTX → CYPH) Soars on Winklevoss‑Backed $50M Zcash Bet as Ticker Changes Today

Cypherpunk Technologies (CYPH) Soars After Zcash Pivot: What Investors Need to Know on November 14, 2025

Cypherpunk Technologies (CYPH), formerly Leap Therapeutics, surged 70–90% intraday to over $3.00 on November 14, with trading volume topping 200 million shares. The company rebranded and spent $50 million to buy about 1.25% of Zcash’s supply after a private placement led by Winklevoss Capital. CYPH’s stock saw extreme volatility, swinging over 100 percentage points during the session.
14 November 2025
··
Cypherpunk Technologies (LPTX → CYPH) Soars on Winklevoss‑Backed $50M Zcash Bet as Ticker Changes Today

CYPH Debuts: Cypherpunk Technologies (ex‑Leap Therapeutics) starts trading, files $200M ATM, posts Q3 results and details $50M Zcash treasury — 13 Nov 2025

Cypherpunk Technologies Inc., formerly Leap Therapeutics, began trading as CYPH on Nasdaq Thursday after shifting its focus from cancer drugs to a digital-asset treasury strategy centered on Zcash. Shares swung between $1.34 and $1.98 in volatile trading. The company disclosed a $50 million Zcash purchase and filed to sell up to $200 million in stock through Cantor Fitzgerald. Q3 net loss narrowed to $3.3 million.
13 November 2025
··
Cypherpunk Technologies (LPTX → CYPH) Soars on Winklevoss‑Backed $50M Zcash Bet as Ticker Changes Today

Cypherpunk Technologies (LPTX → CYPH) Soars on Winklevoss‑Backed $50M Zcash Bet as Ticker Changes Today

Leap Therapeutics rebranded as Cypherpunk Technologies Inc. and changed its Nasdaq ticker from LPTX to CYPH on November 13, 2025. The company raised $58.88 million in a private placement led by Winklevoss Capital and spent $50 million buying 203,775 Zcash. Shares surged up to 440% after the announcement, with LPTX trading near $2.05 and ZEC at $502 early Thursday. Q3 results show a sharply reduced net loss as biotech spending falls.
13 November 2025
···
Leap Therapeutics (LPTX) Rebrands as “Cypherpunk,” Buys $50M in Zcash; Ticker to Change to CYPH on Nov. 13 — Q3 Results and New $200M ATM Filed (Nov. 12, 2025)

Leap Therapeutics (LPTX) Rebrands as “Cypherpunk,” Buys $50M in Zcash; Ticker to Change to CYPH on Nov. 13 — Q3 Results and New $200M ATM Filed (Nov. 12, 2025)

Leap Therapeutics will rebrand as Cypherpunk Technologies and begin trading under the ticker CYPH on Nov. 13. The company disclosed it purchased about $50 million in Zcash for its new digital-asset treasury. Q3 net loss narrowed to $3.3 million from $18.2 million a year ago. A $200 million at-the-market equity program was filed with Cantor Fitzgerald.
12 November 2025
··

Stock Market Today

  • Noteworthy Wednesday Options Activity in RVLV, SOFI, and BE
    April 29, 2026, 3:56 PM EDT. Options trading surged Wednesday for Revolve Group Inc (RVLV), SoFi Technologies Inc (SOFI), and Bloom Energy Corp (BE), key components of the Russell 3000 index. RVLV saw 13,841 contracts traded, driven by strong interest in the $30 strike call expiring May 2026, representing 171% of its average daily volume. SOFI options reached 883,275 contracts, with the $32 strike call for June 2026 leading, marking 163% of its typical daily share volume. BE registered 165,808 contracts, spurred by the $300 strike call expiring May 2026, tallying 163% of its average daily trades. These volumes highlight heightened investor focus on select long-dated call options. Today's data signals notable activity in these names among Russell 3000 components.

Latest article

Vita Coco Stock Surges After COCO Earnings Beat and Coconut Water Demand Lifts 2026 Outlook

Vita Coco Stock Surges After COCO Earnings Beat and Coconut Water Demand Lifts 2026 Outlook

29 April 2026
Vita Coco shares jumped 27% Wednesday after first-quarter net sales rose 37% to $180 million, beating analyst expectations. The company raised its 2026 revenue outlook to $720–$735 million and lifted adjusted EBITDA guidance. Diluted earnings reached $0.50 per share, up from $0.31 a year earlier. Gross margin improved to 39.9% despite higher logistics and tariff costs.
Marathon Petroleum Stock Jumps Before Earnings as Refining Margins Put Wall Street on Alert

Marathon Petroleum Stock Jumps Before Earnings as Refining Margins Put Wall Street on Alert

29 April 2026
Marathon Petroleum shares rose 3.2% to $240.05 Wednesday as investors anticipated its May 5 earnings report, following a surge in fuel margins during the first quarter. Phillips 66 and Valero also gained after posting stronger-than-expected results. Marathon’s Robinson refinery in Illinois began planned maintenance in March. U.S. gasoline prices hit $4.18 a gallon, the highest since 2022, according to AAA.
Why MaxLinear Stock Is Surging as AI Data-Center Demand Rewrites the Story

Why MaxLinear Stock Is Surging as AI Data-Center Demand Rewrites the Story

29 April 2026
MaxLinear shares rose about 34% to $69.58 on Wednesday after Loop Capital upgraded the stock and raised its target to $75. The surge followed a first-quarter report showing infrastructure revenue up 136% to become the company’s largest segment. Total revenue climbed 43% to $137.2 million. MaxLinear guided second-quarter revenue to $160–$170 million, citing strong demand for data-center optical products.
Go toTop